Impairment of Diazoxide-Induced Formation of Reactive Oxygen Species and Loss of Cardioprotection in Connexin 43 Deficient Mice
H earts from heterozygous connexin 43 (Cx43) deficient (Cx43 ϩ/Ϫ ) mice cannot be protected by ischemic preconditioning. 1, 2 Isolated cardiomyocytes are also not protected by ischemic preconditioning, and loss of protection is therefore independent of gap junctions. 3 Most of the signaling pathways of ischemic preconditioning converge at the mitochondria 4 -6 and mitochondrial free radical formation mediates signal transduction through posttranslational modification of redox-sensitive proteins. 7, 8 We have recently demonstrated the presence of Cx43 in the mitochondria and the increase of its mitochondrial content with ischemic preconditioning. 9 Now we attempted to define the functional role of Cx43 in the mitochondria by use of diazoxide, which stimulates the formation of reactive oxygen species (ROS). Diazoxide was compared with menadione, which generates superoxide at multiple intracellular sites caused by redox cycling reactions catalyzed by several flavoenzymes. 10 The cardioprotective effects elicited by diazoxide and menadione have been attributed to ROS formation. 7, 8, 11, 12 ROS formation by diazoxide was also compared with that by valinomycin, which is a potassium ionophore 13 and assumed to induce ROS formation secondary to potassium influx into mitochondria and matrix swelling. 14 
Materials and Methods
All experiments were performed according to the guidelines of the American Physiological Society and approved by the local bioethical committee on animal experimentation.
Western Blotting
Total cardiac Cx43 content was determined as described, 1 and the localization of Cx43 at the mitochondria was measured as the ratio of Cx43 to the adenine nucleotide transporter in isolated mitochondria of 6 WT and Cx43 ϩ/Ϫ each. 9
In Vitro Experiments
Cardiomyocytes were isolated from Cx43 ϩ/Ϫ and WT mice, as previously described. 3 Simulated ischemia was induced by pelleting cardiomyocytes in hypoxic solution (pHϭ6.5), sealed with a layer of mineral oil. 3 Cardiomyocytes were incubated with diazoxide (200 or 500 mol/L) or menadione (2 mol/L) (Sigma Aldrich, Germany) for 30 minutes followed by 15 minutes wash-out before simulated ischemia. At 0, 60, and 120 minutes of simulated ischemia, aliquots from each group were subjected to simulated reperfusion, ie, resuspended in oxygenated, iso-osmolar (at 0 minutes: 310 mOsm/L, pHϭ7.4) or hypo-osmolar solution (at 60 and 120 minutes: 250 mOsm/L, pHϭ7.4). Images were taken after 3 to 5 minutes, comprising Ն200 cells per sample for offline quantification of cell viability (trypan blue exclusion). 3 For measurement of ROS formation, cardiomyocytes from Cx43 ϩ/Ϫ and WT mice were incubated with diazoxide (200 mol/L), menadione (2 mol/L), valinomycin (10nmol/L; a concentration which did not cause significant cellular contraction but ROS formation), or vehicle (0.1% DMSO, Sigma Aldrich) and 2 mol/L reduced MitoTracker Red (MTR, Invitrogen, Germany) for 30 minutes. MTR, when oxidized by H 2 O 2 , is fluorescent and covalently bound to mitochondrial structures. 15 Cardiomyocytes were then washed twice and transferred to an inverted microscope (Axiovert 100 TV, Zeiss) equipped with a fluorescence-sensitive CCD camera (T.I.L.L. Photonics). ROS formation was quantified from the mean fluorescence of 70 to 100 randomly selected rod-shaped cells per sample. The investigator was blinded for the genotype in all experiments.
In Vivo Experiments
Myocardial infarction was induced in WT or heterozygous Cx43 ϩ/Ϫ mice, as previously described. 1 The left anterior descending coronary artery was occluded for 30 minutes, followed by 120 minutes of reperfusion. Diazoxide (5 mg/kg), menadione(37 g/kg) or saline was injected into the jugular vein 30 minutes before ischemia. After removal of the heart, infarct size and area at risk were measured by TTC and Evans blue staining. 2 Data are expressed as meanϮSEM. For comparison of ROS formation and cell viability between untreated and treated groups, two-way ANOVA was used. For the analysis of in vivo infarct size data, two-way ANOVA was used. Fisher's least-significance test was performed when significant overall effects were detected. PϽ0.05 was considered significant.
Results

Western Blotting
Total cardiac Cx43 content in Cx43 ϩ/Ϫ mice was 56Ϯ9% of that in WT; 1 the Cx43/adenine nucleotide transporter ratio in Cx43 ϩ/Ϫ isolated mitochondria was 21Ϯ7% of that in WT, indicating that the mitochondrial Cx43-deficiency was at least as pronounced as total cardiac Cx43 deficiency.
Mitochondrial ROS Formation in Response to Diazoxide, Menadione, and Valinomycin in Cx43 Deficient Cardiomyocytes
Diazoxide (200 mol/L) increased ROS formation by 43Ϯ10% versus vehicle control in WT, but only by 18Ϯ4% in Cx43 ϩ/Ϫ cardiomyocytes; increase of the diazoxide concentration to 500 mol/L did not further increase ROS formation in Cx43 ϩ/Ϫ (13Ϯ3%, nϭ4 mice). Menadione induced similar ROS formation in WT and in Cx43 ϩ/Ϫ cardiomyocytes, by 28Ϯ9% and 34Ϯ15%, respectively (Figure 1 ). Also, valinomycin induced similar ROS formation in WT and Cx43 ϩ/Ϫ cardiomyocytes by 46Ϯ11% and 43Ϯ12%, respectively ( Figure 1) .
No Protection by Diazoxide in Isolated Cardiomyocytes and in Hearts In Situ From Cx43-Deficient Mice
In isolated cardiomyocytes, viability remained relatively stable during normoxia: WT (51Ϯ1% at baseline versus 40Ϯ2% at 60 minutes and 39Ϯ2% at 120 minutes) and Cx43 ϩ/Ϫ (52Ϯ1% at baseline versus 40Ϯ1% at 60 minutes and 40Ϯ3% at 120 minutes). Simulated ischemia/reperfusion reduced viability (at 60 minutes: WT: 11Ϯ1%, Cx43 ϩ/Ϫ : ϩ/Ϫ (nϭ5 mice) and WT (nϭ5 mice). C, ROS formation by valinomycin (10nmol/L) was also not different between Cx43 ϩ/Ϫ (nϭ5 mice) and WT (nϭ5 mice). *PϽ0.05 vs WT.
12Ϯ2%; at 120 minutes: WT: 7Ϯ1%, Cx43 ϩ/Ϫ : 8Ϯ1%, all PϽ0.01 versus baseline and normoxia). Diazoxide preserved viability in cardiomyocytes of WT (at 60 minutes: 22Ϯ2%; at 120 minutes: 17Ϯ2%, PϽ0.01 versus simulated ischemia/ reperfusion), but not of Cx43 ϩ/Ϫ mice (at 60 minutes: 15Ϯ3%; at 120 minutes: 9Ϯ1%) (Figure 2 ). With menadione, viability was increased both in WT (at 60 minutes: 23Ϯ4% versus 16Ϯ1%, at 120 minutes: 19Ϯ1% versus 14Ϯ2%) and in Cx43 ϩ/Ϫ cardiomyocytes (at 60 minutes: 23Ϯ2% versus 17Ϯ1%, at 120 minutes: 20Ϯ2% versus 15Ϯ1%, all PϽ0.05) (Figure 3) .
Infarct size following ischemia/reperfusion (I/R) was not different between WT and Cx43 ϩ/Ϫ (Figure 4 ). Infarct size was reduced with diazoxide in WT, but not in Cx43 ϩ/Ϫ mice. In contrast, menadione reduced infarct size both in WT and in Cx43 ϩ/Ϫ mice ( Figure 4 ).
Discussion
Apart from the role of Cx43 in the intercellular communication and propagation of ischemic cell death, 16, 17 Cx43 is important for protection by ischemic preconditioning. [1] [2] [3] In the rat heart, a decrease of Cx43 at gap junctions during myocardial ischemia was observed, whereas total Cx43 expression was unchanged, suggesting alternative subcellular localizations. 18 Indeed, during oxidative stress translocation of Cx43 to the mitochondria has been reported in endothelial cells. 19 Recently, we have demonstrated that Cx43 is present in the mitochondria of cardiomyocytes and that its mitochondrial content is increased following ischemic preconditioning. 9 In the present study, diazoxide before ischemia/reperfusion reduced infarct size, confirming previous reports in other species. 6 In line with our previous findings on ischemic preconditioning, 3 diazoxide was also effective in isolated WT cardiomyocytes and thus in the absence of gap junctions. Cx43 deficiency abolished the protection afforded by ischemic preconditioning and diazoxide in isolated and in situ cardiomyocytes, suggesting that Cx43 is part of the preconditioning signal cascade triggered at the level or upstream of mitochondria.
A functional role of Cx43 in mitochondria is supported by our finding of a reduced ROS signal in response to diazoxide in Cx43 ϩ/Ϫ cardiomyocytes. In contrast, the potassium ionophore valinomycin and menadione induced similar ROS formation in WT and Cx43 ϩ/Ϫ cardiomyocytes, indicating a specific defect in the diazoxide response with Cx43 deficiency. Also, the signaling cascade downstream of mitochondria was not affected by Cx43 deficiency, as ROS formation induced by menadione still resulted in improved viability following simulated ischemia/reoxygenation in isolated cardiomyocytes and reduced infarct size in hearts from both WT and Cx43 ϩ/Ϫ mice. In conclusion, cardiomyocytes of Cx43 ϩ/Ϫ mice have a specific functional deficit in ROS formation in response to diazoxide and accordingly less protection.
